Why Batteries, Bauxite and Magnets Are Becoming Defence Priorities
Washington targets critical material dependencies across batteries, bauxite and magnets
Electric Powertrain Market to reach US$257.09bn
The global market is expected to expand from US$75.67bn in 2026 to US$257.09bn by 2036, at a 13.0% CAGR
Can Moderna Make mRNA Work in Flu?
Moderna’s flu approval tests whether mRNA can deliver commercial scale
EV Charging Infrastructure Market to reach US$166.36bn
The global market is expected to expand from US$43.70bn in 2026 to US$166.36bn by 2036, at a 14.3% CAGR
EV Battery Systems Market to reach US$459.75bn
The global market is expected to expand from US$142.55bn in 2026 to US$459.75bn by 2036, at a 12.4% CAGR
Automotive Power Electronics & Semiconductor Market to reach US$117.20bn
The global market is expected to expand from US$32.28bn in 2026 to US$117.20bn by 2036, at a 13.8% CAGR
Washington Targets Missile and Drone Weak Links
Washington targets missile and drone bottlenecks across critical defence supply chains
Biologic Success Starts with Drug Delivery
Drug delivery is reshaping biologics development, manufacturing, access and competition
US Missile-Defence Deals Reach Deeper into the Supply Chain
Washington targets missile-supply bottlenecks to expand PAC-3 and THAAD production
Ageing Rewrites Pharma Portfolio Strategy
Ageing reshapes pharma portfolios as access, evidence and delivery determine growth
UK Raises Its Combat Air Ambitions as Canada Joins GCAP
Canada joins GCAP as Britain accelerates its next-generation combat-air strategy
Active Pharmaceutical Ingredients (APIs) Market to reach US$529.7bn
The global Active Pharmaceutical Ingredients (APIs) market is Projected to grow at a CAGR of 6.6% by 2036
When Vaccine Policy Becomes Market Risk
Policy, platforms and manufacturing are reshaping global vaccine market opportunities
Military Communications & COTS Market to Reach US$75.7bn
The global Military Communications & COTS market is projected to grow at a CAGR of 5.8% by 2036
US Defence: Faster, Lower-Cost Production
US reforms target faster production, secure supply chains, lower costs
Cell & Gene Therapy Manufacturing: The Race to Scale
Manufacturing readiness now determines which cell and gene therapies scale
GCAP’s £4.6bn: Contract Tests Military Aviation
GCAP contract tests allied ambition, industrial capacity and combat-air delivery
Precision Medicine: Capturing Value
Precision medicine shifts value from therapies to diagnostics, evidence and access
UK’s £5bn Drone Plan Tests Defence Delivery
UK drone investment tests hybrid force design, funding and delivery
Cell & Gene Therapy Manufacturing Market to Reach US$63.0bn
The global cell & gene therapy manufacturing market is valued at US$13.7 billion in 2026
